23 March 2021
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).
Panther Securities PLC
(the "Company" or the "Group")
Update on refinance, property valuations and dividend
Further to the Company's announcement made on 26 February 2021, the Board provides the following updates:
Refinance
The Group is pleased to confirm that approval has been obtained for the three month extension from both joint lenders ("the Lenders"), to extend the current loan facilities to July 2021 (previously to expire in April 2021)("the Extension Period"). The refinance of our term loans is now expected to receive full credit approval and complete within the Extension Period. The Lenders' solicitors have also now been instructed on the basis that the final credit approval will be obtained from the second Lender.
Property valuations
The final forms of the reports have been issued by the valuers. Although the Lenders still have an opportunity to raise queries, the Board considers it unlikely at this stage that the valuation figures reported on 26 February 2021 will change. We have been informed that the reports are expected to be officially signed off in the next two weeks.
Dividend update
The Directors still consider that it is prudent to wait until full credit approval has been obtained for the refinancing before declaring any dividend.
As such the Group expects to make a further announcement on the dividend and confirm credit approval in due course.
For further information:
Panther Securities plc: | Tel: 01707 667 300 |
Andrew Perloff/ Simon Peters | |
Allenby Capital Limited (Nomad and Joint Broker) | Tel: 020 3328 5656 |
David Worlidge/ Alex Brearley | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.